Marshalltown Times Republican Pfizer, Mylan strengthen ties, create new company Central Iowa • Jul 30, 2019
Clinton Herald Pfizer posts big 2Q profit jump, announces deal with Mylan Eastern Iowa • Jul 29, 2019
Dubuque Telegraph Herald Pfizer to buy Array BioPharma in deal worth $11.4 billion Eastern Iowa • Jun 17, 2019
Fort Madison Daily Democrat Pfizer Acquires Clinical-Stage Biotech Therachon Southeast Iowa • May 8, 2019
Clinton Herald Pfizer 1Q profit jumps 9% on higher drug sales, lower costs Eastern Iowa • Apr 30, 2019
Dubuque Telegraph Herald Biopharmaceuticals power Pfizer in the 1st quarter Eastern Iowa • Apr 30, 2019
Fort Madison Daily Democrat Pfizer Receives Positive CHMP Opinion for TALZENNA (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer Southeast Iowa • Apr 26, 2019
Oelwein Daily Register Pfizer Receives Positive CHMP Opinion for TALZENNA (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer Northeast Iowa • Apr 26, 2019
Fort Madison Daily Democrat Pfizer Hosts Annual Meeting of Shareholders Southeast Iowa • Apr 25, 2019
Fort Madison Daily Democrat Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis Southeast Iowa • Apr 18, 2019
Oelwein Daily Register Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis Northeast Iowa • Apr 18, 2019
Fort Madison Daily Democrat Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders Southeast Iowa • Apr 18, 2019
Oelwein Daily Register Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders Northeast Iowa • Apr 18, 2019
Fort Madison Daily Democrat Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive... Southeast Iowa • Apr 13, 2019
Oelwein Daily Register Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive... Northeast Iowa • Apr 13, 2019